Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.

MLA

Capone, Stefania, et al. “Immunogenicity of a New Gorilla Adenovirus Vaccine Candidate for COVID-19.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 29, no. 8, Aug. 2021, pp. 2412–23. EBSCOhost, https://doi.org/10.1016/j.ymthe.2021.04.022.

APA

Capone, S., Raggioli, A., Gentile, M., Battella, S., Lahm, A., Sommella, A., Contino, A. M., Urbanowicz, R. A., Scala, R., Barra, F., Leuzzi, A., Lilli, E., Miselli, G., Noto, A., Ferraiuolo, M., Talotta, F., Tsoleridis, T., Castilletti, C., Matusali, G., … Vitelli, A. (2021). Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Molecular Therapy : The Journal of the American Society of Gene Therapy, 29(8), 2412–2423. https://doi.org/10.1016/j.ymthe.2021.04.022

Chicago

Capone, Stefania, Angelo Raggioli, Michela Gentile, Simone Battella, Armin Lahm, Andrea Sommella, Alessandra Maria Contino, et al. 2021. “Immunogenicity of a New Gorilla Adenovirus Vaccine Candidate for COVID-19.” Molecular Therapy : The Journal of the American Society of Gene Therapy 29 (8): 2412–23. doi:10.1016/j.ymthe.2021.04.022.